Best of UEG Week - HPB with Carolin Schneider
In this episode, UEG's new Scientific Committee chair Jörn Schattenberg and Carolin Schneider, UEG rising start of 2025, recap the standout science from UEG Week 2025 in Berlin. They discuss highlights from the HPB field, including pivotal phase III data on linerixibat for cholestatic pruritus in PBC, advances in MASLD/MASH therapies such as FGF21 analogues and resmetirom, and new insights into liquid biopsy and AI-assisted imaging for pancreatic lesions. The conversation also explores simvastatin’s potential in preventing recurrent pancreatitis and reflects on the value of collaboration, precision medicine, and prospective clinical trials showcased at UEG Week.